ÂÜÀòÂÒÂ×

Sally Oxenford is an experienced scientist with a strong background in medicinal chemistry and drug discovery. Currently serving as Senior Scientist II at Artios since May 2022, Sally previously worked as a Senior Scientist at Eurofins Discovery from April 2021 to April 2022. Prior to that, Sally held the position of Lead Medicinal Chemist in the Translational Research Office Drug Discovery Group at University College London from November 2012 to March 2021. Sally's industry experience includes roles as Medicinal Chemist at Cellzome and Research Scientist at Piramed. Academic qualifications include a Doctor of Philosophy (PhD) in Organic Chemistry and an MChem in Chemistry, both obtained from the University of York.